A method for remote programming a therapy device for neurostimulation comprises: generating a stimulation program for the therapy device by means of a clinician programmer; transferring the stimulation program to a patient programmer; loading the stimulation program on the therapy device from the patient programmer; and increasing a stimulation amplitude of the stimulation program by means of the patient programmer. An initial stimulation amplitude setting of the stimulation program is limited to a minimal dose amplitude.

A system for minimizing misalignment notifications for a TETS having an implantable blood pump, an external controller having a power source and a processing circuitry, a transmission coil in communication with the external controller, a receiving coil configured for transcutaneous inductive communication with the transmission coil, and an implantable controller in communication with the receiving coil and the implantable blood pump. The implantable controller having a power source configured to receive power from the receiving coil. The processing circuitry may be configured to: operate in a first mode where an alert is generated when a power efficiency transfer between the transmission coil and the receiving coil is below a first predetermined threshold; and operate in a second mode where the alert is only generated when the power remaining in the power source for the implantable controller is below a first predetermined power source threshold.

A TETS having an external controller having a power source, a transmission coil in communication with the external controller, a receiving coil configured for transcutaneous inductive communication with the transmission coil, and an implantable controller in communication with the receiving coil and an implantable blood pump. The implantable controller has a battery configured to receive power from the receiving coil and the external controller is configured to categorize power transfer states based on predetermined thresholds of efficiency and power demand, and user display states (associated with optional configurable notifications) based on the power transfer states and predetermined temperature thresholds of the transmission coil.

Various embodiments of a transcutaneous energy transfer system are disclosed. The system includes an internal component adapted to be disposed within a body of a patient and an external component adapted to be disposed outside the body of the patient. The external component includes an external controller that is adapted to determine whether an internal coil of the internal component is electromagnetically disconnected from an external coil of the external component. If electromagnetically disconnected, then the external controller is adapted to determine a reconnection time threshold based upon at least one of a power transfer efficiency value between the internal coil and the external coil, a charge state of an internal power source, or a power consumption value of an implantable device, and output a charging alarm if a time interval when the internal coil is electromagnetically disconnected from the external coil exceeds the reconnection time threshold.

A wearable defibrillator includes garment configured to be worn by a patient, treatment electrodes configured to apply electric current to the patient, and an alarm module configured to provide audio, visual, and haptic notifications. The notifications are configured to indicate that an electric current will be administered imminently, and prompt the patient to provide a response input. The wearable defibrillator includes a motion sensor configured to detect motion and a lack of motion of the patient, and a controller in electrical communication with the alarm module and the motion sensor. The controller is configured to monitor for the response input, cause administration of the electric current to be delayed or cancelled if the response input is received and motion of the patient is detected, and cause administration of the electric current to be delivered if no response input from the patient is received and a lack of motion is detected.

Semi-autonomous vehicle apparatus which is controlled by a plurality of control sources includes a vehicle which may function autonomously and apparatus for control of the vehicle by either an onboard driver or a driver not situated onboard. The vehicle may also be controlled by an off-vehicle computational device. Hierarchy setting apparatus determines which one or combination of the possible control entities take priority. Persons using the apparatus are identified by either a password or, preferably by providing identification based on a biologic feature. Management of impaired vehicle operators is provided for.

A method for determining usable capacity of a battery of an active implantable medical device comprising a radiofrequency (RF) communication unit for transmitting data by RF over a communication period, wherein the usable capacity of the battery enables the active implantable medical device to transmit data by RF via the RF communication unit. The method includes measuring a value for the voltage of the battery which is representative of an instantaneous voltage drop of the battery as a result of a current draw on the battery, comparing the voltage of the battery with a predetermined threshold voltage VBS, and transmitting an alert message to a second device when the measured voltage of the battery crosses the predetermined threshold voltage.

Methods of improving addiction in a patient in need thereof are provided. Methods include exposing the patient to drug related cues and measuring the patient's craving levels or physiological levels during or after cue exposure to determine the patient's status or condition. Such a determination can indicate whether the patient is at risk of engaging in the addictive activity and can guide therapeutic intervention.

Methods of improving addiction in a patient in need thereof are provided. Methods include using focused ultrasound, deep brain stimulation and/or transcranial magnetic stimulation and multi-dimensional monitoring of the patient to determine whether the focused ultrasound, deep brain stimulation, and/or transcranial magnetic stimulation improves the patient's addiction. Based on this determination, the focused ultrasound, deep brain stimulation, and/or transcranial magnetic stimulation can be adjusted to improve the patient's addiction.

Methods and systems for use of the Q-wave to R-wave interval to guide placement of a leadless cardiac pacemaker are disclosed. An implant delivery device is equipped with sensing electrodes to sense R-wave onset in a ventricle of a patient's heart to allow placement at a location of last or latest onset of the R-wave. Guidance tools are provided to assist in determination of the Q-wave to R-wave interval during implantation. For a chronic system, a cooperative approach is disclosed in which an implantable medical device and a leadless cardiac pacemaker exchange data to determine Q-wave to R-wave intervals and enhance cardiac resynchronization therapy delivery by the leadless cardiac pacemaker.